uniQure Announces the Nomination of Leonard E. Post, Ph.D. to its Board of Directors
17 avr. 2020 07h00 HE
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, April 17, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...